Entity

Time filter

Source Type


Tolosa L.,Instituto Investigacion Sanitaria La Fe IIS La Fe | Gomez-Lechon M.J.,Instituto Investigacion Sanitaria La Fe IIS La Fe | Gomez-Lechon M.J.,CIBER ISCIII | Donato M.T.,Instituto Investigacion Sanitaria La Fe IIS La Fe | And 2 more authors.
Archives of Toxicology | Year: 2015

High-content screening is the application of automated microscopy and image analysis to both cell biology and drug discovery. Over the last decade, this technique has emerged as a useful technology that allows the simultaneous measurement of different parameters at a single-cell level. Hepatotoxicity is a compelling reason for drug nonapprovals and withdrawals. It is recognized that the safety of a compound cannot be based on a single in vitro assay, and existing methods are not predictive of drug-induced toxicity. However, different HCS assays have been recently demonstrated as being powerful for identifying different mechanisms implicated in drug-induced toxicity with high sensitivity and specificity. These assays integrate the data obtained from different cell function indicators and can be easily incorporated into basic screening processes for the safety evaluation and selection of drug candidates; thus, they contribute greatly to lessen the likelihood of drug failure. Exploring the use of cellular imaging technology in drug-induced liver injury by reviewing the different tests proposed provides evidence that this technology has a strong impact on drug discovery. © 2015, Springer-Verlag Berlin Heidelberg. Source


Tolosa L.,Instituto Investigacion Sanitaria La Fe IIS La Fe | Carmona A.,Instituto Investigacion Sanitaria La Fe IIS La Fe | Castell J.V.,Instituto Investigacion Sanitaria La Fe IIS La Fe | Castell J.V.,University of Valencia | And 6 more authors.
Archives of Toxicology | Year: 2014

A frequent mechanism for drug-induced liver injury (DILI) is mitochondrial impairment, and early evaluation of new drugs for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. To this end, we designed a high-content screening assay to study mitochondrial-induced hepatotoxicity in HepG2 cells in detail. Simultaneous assessment of mitochondrial mass and cell viability in cells exposed for 24 h to compounds provides preliminary information on the mitochondrial- or nonmitochondrial-related hepatotoxic potential of compounds. To fully address the mechanisms implicated in mitochondrial impairment, prelethal changes in mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial permeability transition, intracellular calcium concentration and apoptotic cell death were studied in cells incubated for 1 h with compounds. The assay correctly classified a set of well-known mitochondrial toxicants and negative controls and revealed high sensitivity for the detection of mitochondrial DILI and the establishment of different mitochondrial toxicity risks (low to high). This procedure was used for analysing the potential mitochondrial impairment of six statins to determine their clinical risk. All the tested statins produced mitochondrial impairment, although they showed different levels of toxicity (low-medium toxicity risk). The results suggest that this cell-based assay is a promising in vitro approach to predict the potential of drug candidates to induce mitochondrial-associated hepatotoxicity. © 2014 Springer-Verlag Berlin Heidelberg. Source

Discover hidden collaborations